Malignant lymphomas involving lung and pleura

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Primary malignant lymphomas represent approximately 0.5 % of all primary neoplasms of the lung. By contrast, secondary involvement of the lung in patients with systemic lymphoma is common. Most of the primary malignant lymphomas are non-Hodgkin's lymphomas of B-cell lineage and, overall, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is the most common type. The second most frequent lymphoma of the lung is diffuse large B-cell lymphoma (DLBCL), some of them representing large cell transformation of a previous MALT lymphoma. Hodgkin's lymphoma rarely occurs in extranodal sites. Other malignant lymphomas that involve lung and pleura are also discussed including distinct entities such as lymphomatoid granulomatosis, primary effusion lymphomas (PEL), and DLBCL associated with chronic inflammation, also known as pyothorax-associated lymphoma (PAL).

Original languageEnglish (US)
Title of host publicationDiagnostic Pathology of Pleuropulmonary Neoplasia
PublisherSpringer New York
Pages319-347
Number of pages29
ISBN (Print)9781441907875, 9781441907868
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Pleura
Lymphoma
Marginal Zone B-Cell Lymphoma
Lung
Lymphoma, Large B-Cell, Diffuse
Lymphomatoid Granulomatosis
Primary Effusion Lymphoma
Pleural Empyema
Cell Lineage
Hodgkin Disease
Non-Hodgkin's Lymphoma
Lung Neoplasms
B-Lymphocytes
Inflammation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Vega, F. (2013). Malignant lymphomas involving lung and pleura. In Diagnostic Pathology of Pleuropulmonary Neoplasia (pp. 319-347). Springer New York. https://doi.org/10.1007/978-1-4419-0787-5

Malignant lymphomas involving lung and pleura. / Vega, Francisco.

Diagnostic Pathology of Pleuropulmonary Neoplasia. Springer New York, 2013. p. 319-347.

Research output: Chapter in Book/Report/Conference proceedingChapter

Vega, F 2013, Malignant lymphomas involving lung and pleura. in Diagnostic Pathology of Pleuropulmonary Neoplasia. Springer New York, pp. 319-347. https://doi.org/10.1007/978-1-4419-0787-5
Vega F. Malignant lymphomas involving lung and pleura. In Diagnostic Pathology of Pleuropulmonary Neoplasia. Springer New York. 2013. p. 319-347 https://doi.org/10.1007/978-1-4419-0787-5
Vega, Francisco. / Malignant lymphomas involving lung and pleura. Diagnostic Pathology of Pleuropulmonary Neoplasia. Springer New York, 2013. pp. 319-347
@inbook{414991c247fc46a8afa03d60f0d314dd,
title = "Malignant lymphomas involving lung and pleura",
abstract = "Primary malignant lymphomas represent approximately 0.5 {\%} of all primary neoplasms of the lung. By contrast, secondary involvement of the lung in patients with systemic lymphoma is common. Most of the primary malignant lymphomas are non-Hodgkin's lymphomas of B-cell lineage and, overall, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is the most common type. The second most frequent lymphoma of the lung is diffuse large B-cell lymphoma (DLBCL), some of them representing large cell transformation of a previous MALT lymphoma. Hodgkin's lymphoma rarely occurs in extranodal sites. Other malignant lymphomas that involve lung and pleura are also discussed including distinct entities such as lymphomatoid granulomatosis, primary effusion lymphomas (PEL), and DLBCL associated with chronic inflammation, also known as pyothorax-associated lymphoma (PAL).",
author = "Francisco Vega",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-4419-0787-5",
language = "English (US)",
isbn = "9781441907875",
pages = "319--347",
booktitle = "Diagnostic Pathology of Pleuropulmonary Neoplasia",
publisher = "Springer New York",

}

TY - CHAP

T1 - Malignant lymphomas involving lung and pleura

AU - Vega, Francisco

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Primary malignant lymphomas represent approximately 0.5 % of all primary neoplasms of the lung. By contrast, secondary involvement of the lung in patients with systemic lymphoma is common. Most of the primary malignant lymphomas are non-Hodgkin's lymphomas of B-cell lineage and, overall, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is the most common type. The second most frequent lymphoma of the lung is diffuse large B-cell lymphoma (DLBCL), some of them representing large cell transformation of a previous MALT lymphoma. Hodgkin's lymphoma rarely occurs in extranodal sites. Other malignant lymphomas that involve lung and pleura are also discussed including distinct entities such as lymphomatoid granulomatosis, primary effusion lymphomas (PEL), and DLBCL associated with chronic inflammation, also known as pyothorax-associated lymphoma (PAL).

AB - Primary malignant lymphomas represent approximately 0.5 % of all primary neoplasms of the lung. By contrast, secondary involvement of the lung in patients with systemic lymphoma is common. Most of the primary malignant lymphomas are non-Hodgkin's lymphomas of B-cell lineage and, overall, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is the most common type. The second most frequent lymphoma of the lung is diffuse large B-cell lymphoma (DLBCL), some of them representing large cell transformation of a previous MALT lymphoma. Hodgkin's lymphoma rarely occurs in extranodal sites. Other malignant lymphomas that involve lung and pleura are also discussed including distinct entities such as lymphomatoid granulomatosis, primary effusion lymphomas (PEL), and DLBCL associated with chronic inflammation, also known as pyothorax-associated lymphoma (PAL).

UR - http://www.scopus.com/inward/record.url?scp=84957647422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957647422&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-0787-5

DO - 10.1007/978-1-4419-0787-5

M3 - Chapter

SN - 9781441907875

SN - 9781441907868

SP - 319

EP - 347

BT - Diagnostic Pathology of Pleuropulmonary Neoplasia

PB - Springer New York

ER -